Cotinga Pharmaceuticals Inc. (COTQF)

[rbd317]

Critical Outcome Technologies Inc. Strengthens Its Investor Relations Outreach

Engages U.S. Firm With Strong Institutional Focus

http://www.marketwired.com/press-release/-2006290.htm

LONDON, ON--(Marketwired - April 02, 2015) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") announced today it has retained Stonegate Capital Partners, Inc. ("Stonegate") to provide strategic investor relations services on behalf of the Company in the United States with a specific focus on the U.S. small-cap life science institutional investment community.

Stonegate is a Dallas-based consulting firm providing a full range of services to help a select group of public company clients build awareness, manage investor expectations, and broaden and strengthen investor relationships with a strong focus on institutional investors.
"With a broad range of services and extensive institutional investor relations and capital market experience, we expect that Stonegate will be a real asset to the Company in developing durable relationships with institutional investors," said Dr. Wayne Danter, President & Chief Executive Officer. "We have a great story to tell and have targeted early May for our initial company presentations to institutions in the U.S."

The agreement is for an initial six month term with the ability to terminate after three months upon ten days written notice, and if not terminated at that time then, any time after the initial six month period upon ten days written notice. Under the engagement, Stonegate receives a monthly consulting fee of $5,000 USD. The agreement is subject to the acceptance of the TSX Venture Exchange.

$COTQF